malignant, growth, gland, men, bladder, bones, grow, older, , Drug Views, drugs, Medical, Information, Health, Drugs, Conditions, Pharmacy, Pills http://www.drugviews.com/articles.php en-us Ateom.com - Website Power Tools cancer. Ablatherm HIFU will be distributed throughout China by Shaw Han Biomedical Co. Ltd.]]> Thu, 26 Aug 2010 08:17:34 -0400 http://www.drugviews.com/articles.php?t=EDAP-TMS-introduces-Albatherm-HIFU-device-for-prostate-cancer-in-Chinese-healthcare-market online in Cancer, a peer-reviewed journal of the American Cancer Society, the study finds that treatments that may be less expensive in the short-term may have higher long-term costs.]]> Mon, 23 Aug 2010 01:06:00 -0400 http://www.drugviews.com/articles.php?t=Scientific-findings-provide-new-information-on-prostate-cancer-care Fri, 20 Aug 2010 05:04:39 -0400 http://www.drugviews.com/articles.php?t=Research-finds-increased-diagnostic-activity-among-men-with-family-history-of-prostate-cancer cancer community joins together in congratulating Us TOO International Prostate Cancer Education & Support Network in their 20th anniversary of continued prostate cancer support, education and advocacy.]]> Thu, 19 Aug 2010 05:39:02 -0400 http://www.drugviews.com/articles.php?t=Us-TOO-International-Prostate-Cancer-Education-Support-Network-recognized-for-20-years-of-service cancer, according to the American Cancer Society. This year more than 27,000 men are expected to die of the disease, which is the second-leading cause of cancer death in men.]]> Wed, 18 Aug 2010 07:13:45 -0400 http://www.drugviews.com/articles.php?t=Loyola-University-Medical-Center-to-offer-free-prostate-cancer-screenings study by The Cancer Institute of New Jersey (CINJ), new evidence proves the safety of a robotic prostatectomy with the lowest complication rates in prostate cancer treatment. This comes as no surprise to Dr. David Samadi, Chief of the Division of Robotics and Minimally Invasive Surgery in the Department of Urology at The Mount Sinai Medical Center in New ]]> Wed, 18 Aug 2010 06:25:00 -0400 http://www.drugviews.com/articles.php?t=Robotic-prostatectomy-has-low-complication-rates-CINJ-study doctor.Several previous studies have looked at the possibility of an association between aspirin use and a reduced risk of prostate cancer.In the ]]> Mon, 16 Aug 2010 00:51:00 -0400 http://www.drugviews.com/articles.php?t=Daily-dose-of-aspirin-may-reduce-prostate-cancer-risk-US-Study online August 12 in The Journal of the National Cancer Institute.]]> Fri, 13 Aug 2010 01:47:00 -0400 http://www.drugviews.com/articles.php?t=Problems-with-analytical-study-design-and-data-misinterpretation-leads-to-biomarker-failure-Report research efforts regarding the discovery of novel technologies for the systemic delivery of RNAi therapeutics.]]> Tue, 10 Aug 2010 05:21:00 -0400 http://www.drugviews.com/articles.php?t=Alnylam-Pharmaceuticals-reports-significant-progress-in-discovery-of-novel-technologies-for-systemic-delivery-of-RNAi-therapeuti Progenics Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has issued a positive opinion for RELISTOR® (methylnaltrexone bromide) subcutaneous injection in pre-filled syringes.]]> Sat, 07 Aug 2010 00:46:36 -0400 http://www.drugviews.com/articles.php?t=Progenics-announces-EMA-CHMP-positive-opinion-for-RELISTOR-in-pre-filled-syringes cancer offers a significantly higher survival rate than either external-beam radiation or hormonal therapies, according to a new study led by researchers at UCSF.The differences among therapies were more prominent at higher levels of cancer risk, and suggest, the researchers say, that in many cases surgery should play a greater role in treatment strategies for patients with prostate cancer that ]]> Sat, 07 Aug 2010 00:31:48 -0400 http://www.drugviews.com/articles.php?t=Surgery-plays-greater-role-in-treatment-strategies-for-patients-with-prostate-cancer-Study surgery should play a greater role in treatment strategies for patients with prostate cancer that ]]> Sat, 07 Aug 2010 00:31:00 -0400 http://www.drugviews.com/articles.php?t=Surgery-offers-high-survival-rate-for-prostate-cancer-patients-Study cancer surgery is removing the cancer-affected gland without side effects. The procedure is estimated to cause long-term sexual dysfunction in half of men.Now, new published research by urologic surgeons at NewYork-Presbyterian Hospital/Columbia University Medical Center presents evidence that a new laser technology used with robotic prostate cancer surgery may reduce the risk of damaging the crucial nerves necessary ]]> Fri, 06 Aug 2010 04:28:00 -0400 http://www.drugviews.com/articles.php?t=New-laser-technology-for-robotic-prostate-cancer-surgery surgery method, research just published by investigators at The Cancer Institute of New Jersey (CINJ) shows new evidence supporting the safety of the robotic procedure - including what is believed to be one of the lowest ]]> Fri, 06 Aug 2010 03:27:00 -0400 http://www.drugviews.com/articles.php?t=Researchers-recommends-robotic-prostatectomy-over-traditional-open-surgery-method drug development and manufacturing services to the international pharmaceutical industry, announced today that it has signed a technology transfer agreement with Dendreon Corporation for commercial supply of proprietary density gradient solutions required during the PROVENGE (sipuleucel-T) manufacturing process.]]> Fri, 06 Aug 2010 01:59:16 -0400 http://www.drugviews.com/articles.php?t=Patheon-Dendreon-announce-signing-of-technology-transfer-agreement Wed, 04 Aug 2010 02:00:00 -0400 http://www.drugviews.com/articles.php?t=Dendreon-second-quarter-revenue-increases-to-2-8-million Stress urinary incontinence is one of the most feared complications of radical prostatectomy. The weighted mean continence rate immediately after catheter removal following robot-assisted laparoscopic radical prostatectomy (RALP) is 25.7%. Evidently, early recovery of urinary continence remains a challenge to be overcome. The Surgery in Motion section of the September issue of European Urology describes the surgical steps of pubovesical complex (PVC)-sparing RALP and ]]> Tue, 03 Aug 2010 04:52:12 -0400 http://www.drugviews.com/articles.php?t=New-surgical-technique-to-maximize-preservation-of-periprostatic-anatomy first to use Elekta VMAT, treating a patient with prostate cancer using a single 100-second arc of radiation. Such rapid treatments change the entire therapy experience for these patients, who have had to remain completely still for seven minutes during radiation delivery for each of 37 ]]> Mon, 02 Aug 2010 11:29:19 -0400 http://www.drugviews.com/articles.php?t=ARO-uses-Elekta-VMAT-system-for-prostate-cancer-patients high complexity, CLIA-certified laboratory focused on oncology and molecular diagnostics.]]> Mon, 02 Aug 2010 08:07:33 -0400 http://www.drugviews.com/articles.php?t=IRIS-International-closes-AlliedPath-acquisition time a cell-of-origin for human prostate cancer, a discovery that could result in better predictive and diagnostics tools and the development of new and more effective targeted treatments for the disease.]]> Fri, 30 Jul 2010 04:55:15 -0400 http://www.drugviews.com/articles.php?t=New-discovery-may-lead-to-effective-targeted-treatments-for-prostate-cancer-UCLA